Halis Kaan Akturk MD
Diabetes, Lipid Metabolism
Associate professor of medicine and pediatrics
Join to View Full Profile
Barbara Davis Center for DiabetesAurora, CO 80045
Dr. Akturk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Halis Akturk is an endocrinologist in Aurora, CO and is affiliated with University of Colorado Hospital. He received his medical degree from Istanbul University Faculty of Medicine and has been in practice 10 years. He also speaks multiple languages, including Turkish and German. He is experienced in type i diabetes mellitus, tumor immunotherapy, insulin pump management, type ii diabetes, and continuous glucose monitoring.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2011 - 2014
Istanbul University FomClass of 2007
Certifications & Licensure
CO State Medical License 2016 - 2027
FL State Medical License 2014 - 2018
NE State Medical License Active through 2013
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Young Internists of 2011 European Federation of Internal Medicine, 2011
Publications & Presentations
PubMed
- Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes.Halis Kaan Akturk, Kagan Ege Karakus, Boyang Chen, Tomas C Walker
Diabetes Technology & Therapeutics. 2025-09-11 - 2 citationsSemaglutide in Adults with Type 1 Diabetes and Obesity.Viral N Shah, Halis K Akturk, Davida Kruger, Andrew Ahmann, Anuj Bhargava
NEJM Evidence. 2025-08-01 - Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps.Salwa J Zahalka, Halis K Akturk, Rodolfo J Galindo, Viral N Shah, Cecilia C Low Wang
Endocrine Practice. 2025-08-01
Journal Articles
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine AutoimmunityHalis Kaan Akturk, Aaron W Michels, The Journal of Clinical Endocrinology and Metabolism
- The Cortisol Stress Response Induced by Surgery: A Systematic Review and Meta‐AnalysisHalis Kaan Akturk, Irina Bancos, Clinical Endocrinology
- Linagliptin for the treatment of Type 2 diabetesTella SH, Akturk HK, Rendell M, Diabetes Management, 2014
Authored Content
- Highlights in ADA 2022 for Diabetes Technologies and TherapeuticsJune 2022
- Highlights in ADA 2021 for Diabetes Technologies and TherapeuticsJuly 2021
Press Mentions
ADA 2025: Progress in Managing Type 1 DiabetesJuly 22nd, 2025- Weekly Semaglutide Improves Blood Sugar and Weight in Adults with Type 1 DiabetesJune 23rd, 2025
- Q&A: How Adults with Type 1 Diabetes Can Become Commercial Airline PilotsMarch 17th, 2025
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
Other Languages
- Turkish, German
External Links
- Akraba Evliligi( Consanguineous marriages and autosomal recessive disorders)http://www.akrabaevliligi.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
